Biotech

All Articles

Daiichi spends Merck $170M to develop lung cancer cells T-cell engager treaty

.Merck &amp Co. has swiftly recovered a few of the prices of its Spear Rehabs buyout, attracting $17...

BioMarin halts preclinical genetics therapy for heart condition

.After BioMarin performed a spring season clean of its own pipeline in April, the company has decide...

Eisai vegetations molecular glue SEED along with $1.5 B biobucks work

.Big Pharmas continue to be caught to the tip of molecular adhesive degraders. The most up to date p...

Life science debt firm introduces with $600M

.A brand new worldwide lifestyle scientific research credit history organization, referred to as Sym...

BMS ditches TIGIT, walking away from $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing another significant bet coming from the Caforio age, canceling a deal...

Nuvation stops BET prevention after looking at period 1 information

.After taking a look at stage 1 information, Nuvation Bio has actually decided to halt deal with its...

' Medical instinct' led FDA consultants to back Zevra's unusual ailment med

.Zevra Therapies' uncommon health condition drug seems to be to become on the course to approval thi...

Pfizer takes $230M attacked after axing failed DMD genetics treatment

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene therapy failing has blown a $230 million g...

AC Immune sees 'landmark' possible in Alzheimer's medication data

.After greater than two decades of work on neurodegenerative illness, Swiss biotech AC Immune claims...

GSK falls ph. 2 HPV vaccination over absence of best-in-class potential

.GSK has ditched a stage 2 individual papillomavirus (HPV) injection coming from its pipe after choo...